A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies

BACKGROUND: Despite new treatment options for hepatocellular carcinomas (HCC) recently, 5-year survival remains poor, ranging from 50 to 70%, which may attribute to the lack of early diagnostic biomarkers. Thus, developing new biomarkers for early diagnosis of HCC, is extremely urgent, aiming to dec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diagn Pathol
Glavni autori: Wang, Feifei, Wang, Ruliang, Li, Qiuwen, Qu, Xueling, Hao, Yixin, Yang, Jingwen, Zhao, Huixia, Wang, Qian, Li, Guanghui, Zhang, Fengyun, Zhang, He, Zhou, Xuan, Peng, Xioumei, Bian, Yang, Xiao, Wenhua
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5237304/
https://ncbi.nlm.nih.gov/pubmed/28086821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0596-x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items